Inactive Instrument

Other languages Provention Bio, Inc.

Equities

Improving Confidence in Eurozone Economy Lifts French Shares Amid Q1 Results Outpour	23-04-27
Sanofi Completes Provention Bio Acquisition	23-04-27
Sanofi : acquisition de Provention Bio finalisée	23-04-27
Sanofi : finalise l'acquisition de l'américain Provention Bio	23-04-27
Provention Bio, Inc. Announces Management Changes	23-04-27
Sanofi a finalisé l'acquisition de la biotech américaine Provention Bio	23-04-27
Sanofi Closes $3 Billion Acquisition of Provention Bio	23-04-27
Sanofi completed the acquisition of 97.1% stake in Provention Bio, Inc..	23-04-26
Sanofi : période d'attente expirée pour Provention Bio	23-04-26
Sanofi Secures US Antitrust Clearance for $2.9 Billion Provention Bio Takeover	23-04-26
Sanofi Extends Offer Period for Provention Bio Takeover Amid US Regulatory Review	23-04-11
Sanofi y Regeneron presentan los datos de un fármaco contra el cáncer de pulmón del fumador	23-03-23
Aktien New York Schluss: Stabilisierung - Übernahmen stützen Nasdaq	23-03-13
MÄRKTE USA/Wall Street uneinheitlich - Bankenwerte stürzen ab	23-03-13
Bankendrama zet Wall Street onder druk	23-03-13
Sector Update: Health Care Maintaining Monday Rebound	23-03-13
Aktien New York: Stabilisierung trotz Bankenkrise - Übernahmen beflügen Nasdaq	23-03-13
Top Midday Gainers	23-03-13
Sector Update: Health Care	23-03-13
Handel Wall Street volatiel	23-03-13

No results for this search